{"id":838,"date":"2020-01-28T14:42:11","date_gmt":"2020-01-28T14:42:11","guid":{"rendered":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/nouveau-traitement-offert-au-canada\/"},"modified":"2026-03-31T15:25:21","modified_gmt":"2026-03-31T15:25:21","slug":"new-combination-treatment-available-in-canada-2","status":"publish","type":"post","link":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/new-combination-treatment-available-in-canada-2\/","title":{"rendered":"Nouveau traitement offert au Canada"},"content":{"rendered":"<h5><\/h5>\n<h5>Une bonne nouvelle pour les patients atteints d\u2019un cancer du rein et leurs familles.<\/h5>\n<p>Le pembrolizumab (Keytruda\u00ae) utilis\u00e9 en association avec l\u2019axitinib, pour le traitement de premi\u00e8re intention des patients atteints ad\u00e9nocarcinome\u00a0r\u00e9nal\u00a0\u00e0 un\u00a0stade\u00a0avanc\u00e9 est maintenant offert au Canada par l\u2019entremise du Programme d\u2019aide aux patients du fabricant.<\/p>\n<p>Si votre m\u00e9decin croit que cette th\u00e9rapie vous convient, il doit contacter Cancer du rein Canada et nous lui fournirons les renseignements n\u00e9cessaires.<\/p>\n<p>Veuillez nous contacter pour plus d&rsquo;informations.<\/p>\n<p>\u00a0<\/p>\n<p>\u00a0<\/p>\n<hr \/>\n<p>\u00c0 noter : Sant\u00e9 Canada a approuv\u00e9 ce traitement combin\u00e9 le 23 janvier. Cette th\u00e9rapie pour le traitement du cancer du rein <span class=\"tooltipsall tooltip_post_id_13145 classtoolTips154\" data-hasqtip=\"3\">m\u00e9tastatique<\/span> doit \u00eatre \u00e9valu\u00e9e par le Programme pancanadien d\u2019\u00e9valuation des anticanc\u00e9reux (par l\u2019INESSS au Qu\u00e9bec) et si recommand\u00e9e, le gouvernement et les assureurs priv\u00e9s entameront les n\u00e9gociations du prix.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Une bonne nouvelle pour les patients atteints d\u2019un cancer du rein et leurs familles. Le pembrolizumab (Keytruda\u00ae) utilis\u00e9 en association avec l\u2019axitinib, pour le traitement de premi\u00e8re intention des patients atteints ad\u00e9nocarcinome\u00a0r\u00e9nal\u00a0\u00e0 un\u00a0stade\u00a0avanc\u00e9 est maintenant offert au Canada par l\u2019entremise du Programme d\u2019aide aux patients du fabricant. Si votre m\u00e9decin croit que cette th\u00e9rapie vous [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":839,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[40],"year-of-the-new":[32],"class_list":["post-838","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee","tag-nouvelles","year-of-the-new-32"],"_links":{"self":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/comments?post=838"}],"version-history":[{"count":1,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/838\/revisions"}],"predecessor-version":[{"id":840,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/posts\/838\/revisions\/840"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/media\/839"}],"wp:attachment":[{"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/media?parent=838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/categories?post=838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/tags?post=838"},{"taxonomy":"year-of-the-new","embeddable":true,"href":"https:\/\/kidneycancercanada-beta.ubmepsilon.com\/fr\/wp-json\/wp\/v2\/year-of-the-new?post=838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}